This respiratory illness season, wearing a mask is required in patient and resident areas at Sunnybrook. Read our visitor guidelines »

Hospital  >  Departments  >  Medicine  >  Divisions  >  Neurology  >  Neurologists
PAGE
MENU

Medicine care team

Medical Oncology/ Hematology

Dr. Craig Earle, MD, M.Sc.

Scientist
Medical Oncologist

Odette Cancer Centre
Sunnybrook Health Sciences Centre
2075 Bayview Ave
Toronto, ON
M4N 3M5


Phone: 416-480-4757
Fax: 416-480-6002

Education:

  • B.Sc., 1989, biochemistry, University of Ottawa, Canada
  • MD, 1990, medicine, University of Ottawa, Canada
  • M.Sc., 1998, epidemiology, University of Ottawa, Canada
  • Research fellowship, 1998, outcomes and policy research, Harvard Medical School, U.S.

Appointments and Affiliations:

  • Scientist, Evaluative Clinical SciencesOdette Cancer Research Program, Sunnybrook Research Institute
  • Head, clinical translation, Ontario Institute for Cancer Research
  • Professor, department of medicine, University of Toronto
  • Senior scientist and cancer program leader, Institute for Clinical and Evaluative Sciences
  • Medical oncologist, gastrointestinal oncology, Sunnybrook Health Sciences Centre

Research Focus:

  • Health services research in cancer

Research Summary:

Dr. Earle’s research program focuses on using administrative data to evaluate the accessibility, quality, costs and outcomes of care delivered to cancer patients and survivors.

Selected Publications:

See current publications list at PubMed.

  1. Wright AA, Keating NL, Ayanian JZ, Chrischilles EA, Kahn KL, Ritchie CS, Weeks JC, Earle CC, Landrum MB. Family perspectives on aggressive cancer care near the end of life. JAMA. 2016 Jan 19;315(3):284–92.
  2. El Emam K, Farah H, Samet S, Essex A, Jonker J, Kantarcioglu M, Craig Earle. A privacy preserving protocol for tracking participants in phase I clinical trials. J Biomed Inform. 2015 Oct;57:145–62.
  3. Snyder CF, Frick KD, Herbert RJ, Blackford AL, Neville BA, Wolff AC, Carducci MA, Earle CC. Quality of care for comorbid conditions during the transition to survivorship: differences between cancer survivors and noncancer controls. J Clin Oncol. 2013 Mar 20;31(9):1140–8.
  4. Stukel TA, Fisher ES, Alter DA, Guttmann A, Ko DT, Fung K, Wodchis WP, Baxter NN, Earle CC, Lee DS. Association of hospital spending intensity with mortality and readmissions in Ontario hospitals. JAMA. 2012 Mar 14;307(10):1037–45.
  5. Jacobson M, Earle CC, Newhouse JP. Geographic variation in physicians’ responses to a reimbursement change. N Engl J Med. 2011 Dec 1;365(22):2049–52.

Related Links: